Core Insights - Molina Healthcare, Inc. operates in the managed healthcare services sector, focusing on low-income families and individuals through government-sponsored programs, serving approximately 5.2 million members across 18 states as of the end of 2021 [1] Price Target and Analyst Expectations - The consensus price target for Molina's stock has varied, with an initial average of $204, adjusted to $195.2 in the last quarter, reflecting concerns or changes in analyst expectations [3] - Over the past year, the average price target was significantly higher at $234.57, indicating a downward revision possibly due to shifts in the company's performance or broader market conditions [3][6] Earnings Outlook - Molina anticipates a 92.5% decline in earnings per share (EPS) for its fourth-quarter earnings report compared to the previous year, primarily due to rising costs despite expected growth in revenues and premiums [3][6] - Analyst Scott Fidel from Stephens maintains a long-term price target of $300 for Molina, indicating confidence in its future performance despite short-term challenges [4][6] Medicare Segment Impact - Molina's Medicare segment, which accounts for 14.5% of its revenue and contributes 14.6% to its operating medical margin profit, is affected by proposed changes in Medicare Advantage rates by the Centers for Medicare & Medicaid Services (CMS) [5] - The proposed flat 0.09% increase in Medicare Advantage rates for 2027 is significantly lower than the expected 5%, contributing to sector volatility [4] Future Earnings Report - Molina Healthcare will release its earnings report for the fourth quarter and full year ending December 31, 2025, after the market closes on February 5, 2026, followed by a conference call and webcast on February 6, 2026 [5]
Molina Healthcare, Inc. (NYSE: MOH) Overview and Analyst Insights